Fierce Pharma Manufacturing reports India’s Micro Labs has issued a recall for nearly 55,000 bottles of generic Lipitor (atorvastatin calcium) after it failed “impurities testing.” The affected plant, which is in Goa, western India, is separate from the company’s plant in Bangalore that was banned by the FDA for various quality compliance issues. The company “has recalled 6 lots of simvastatin tablets in different dosages, according to the most recent FDA Enforcement Report.”
From the news release of the American Association for Justice.


